BACKGROUND: Glioblastoma multiforme is the most common glioma in adults and carries a poor prognosis, due to tumor recurrence despite aggressive treatment. Such relapse has been attributed to the persistence of glioma stemlike cells (GSCs), a subpopulation of glioma cells with stem cell properties. Thus, targeting these cells will be critical to achieving meaningful improvement in glioblastoma multiforme survival. We investigated the role of β1-integrin signaling as one such potential target. METHODS: We used GSCs isolated from primary human gliomas and maintained in stem cell conditions. We manipulated β1-integrin signaling using a self-assembling peptide amphiphile (PA) displaying the IKVAV (isoleucine-lysine-valine-alanine-valine) epitope as well as lentiviral overexpression, and we assayed the effects on downstream effectors and apoptosis using immunofluorescence. RESULTS: We show that β1-integrin expression correlates with decreased survival in glioma patients and that β1-integrin is highly expressed by GSCs. The IKVAV PA potently increases immobilized β1-integrin at the GSC membrane, activating integrin-linked kinase while inhibiting focal adhesion kinase (FAK). The IKVAV PA induces striking apoptosis in GSCs via this FAK inhibition, which is enhanced in combination with inhibition of epidermal growth factor receptor (EGFR). Conversely, lentiviral overexpression of β1-integrin renders GSCs resistant to EGFR inhibition, which was overcome by FAK inhibition. CONCLUSIONS: These observations reveal a role for β1-integrin signaling through FAK in GSC treatment resistance and introduce self-assembling PAs as a novel new therapeutic approach for overcoming this resistance.
BACKGROUND: Glioblastoma multiforme is the most common glioma in adults and carries a poor prognosis, due to tumor recurrence despite aggressive treatment. Such relapse has been attributed to the persistence of glioma stemlike cells (GSCs), a subpopulation of glioma cells with stem cell properties. Thus, targeting these cells will be critical to achieving meaningful improvement in glioblastoma multiforme survival. We investigated the role of β1-integrin signaling as one such potential target. METHODS: We used GSCs isolated from primary human gliomas and maintained in stem cell conditions. We manipulated β1-integrin signaling using a self-assembling peptide amphiphile (PA) displaying the IKVAV (isoleucine-lysine-valine-alanine-valine) epitope as well as lentiviral overexpression, and we assayed the effects on downstream effectors and apoptosis using immunofluorescence. RESULTS: We show that β1-integrin expression correlates with decreased survival in glioma patients and that β1-integrin is highly expressed by GSCs. The IKVAV PA potently increases immobilized β1-integrin at the GSC membrane, activating integrin-linked kinase while inhibiting focal adhesion kinase (FAK). The IKVAV PA induces striking apoptosis in GSCs via this FAK inhibition, which is enhanced in combination with inhibition of epidermal growth factor receptor (EGFR). Conversely, lentiviral overexpression of β1-integrin renders GSCs resistant to EGFR inhibition, which was overcome by FAK inhibition. CONCLUSIONS: These observations reveal a role for β1-integrin signaling through FAK in GSC treatment resistance and introduce self-assembling PAs as a novel new therapeutic approach for overcoming this resistance.
Authors: Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich Journal: Cell Stem Cell Date: 2010-05-07 Impact factor: 24.633
Authors: A Eramo; L Ricci-Vitiani; A Zeuner; R Pallini; F Lotti; G Sette; E Pilozzi; L M Larocca; C Peschle; R De Maria Journal: Cell Death Differ Date: 2006-02-03 Impact factor: 15.828
Authors: Christopher Calabrese; Helen Poppleton; Mehmet Kocak; Twala L Hogg; Christine Fuller; Blair Hamner; Eun Young Oh; M Waleed Gaber; David Finklestein; Meredith Allen; Adrian Frank; Ildar T Bayazitov; Stanislav S Zakharenko; Amar Gajjar; Andrew Davidoff; Richard J Gilbertson Journal: Cancer Cell Date: 2007-01 Impact factor: 31.743
Authors: Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich Journal: Nature Date: 2006-10-18 Impact factor: 49.962
Authors: Haizhong Feng; Giselle Y Lopez; Chung Kwon Kim; Angel Alvarez; Christopher G Duncan; Ryo Nishikawa; Motoo Nagane; An-Jey A Su; Philip E Auron; Matthew L Hedberg; Lin Wang; Jeffery J Raizer; John A Kessler; Andrew T Parsa; Wei-Qiang Gao; Sung-Hak Kim; Mutsuko Minata; Ichiro Nakano; Jennifer R Grandis; Roger E McLendon; Darell D Bigner; Hui-Kuan Lin; Frank B Furnari; Webster K Cavenee; Bo Hu; Hai Yan; Shi-Yuan Cheng Journal: J Clin Invest Date: 2014-07-25 Impact factor: 14.808
Authors: Friedrich Erhart; Matthias Hackl; Hannes Hahne; Johanna Buchroithner; Chen Meng; Simone Klingenbrunner; René Reitermaier; Katrin Fischhuber; Susanna Skalicky; Walter Berger; Sabine Spiegl-Kreinecker; Daniela Lötsch; Gerda Ricken; Bernhard Kuster; Adelheid Wöhrer; Georg Widhalm; Johannes Hainfellner; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus Journal: NPJ Vaccines Date: 2020-01-16 Impact factor: 7.344
Authors: Rajendra P Pangeni; Zhou Zhang; Angel A Alvarez; Xuechao Wan; Namratha Sastry; Songjian Lu; Taiping Shi; Tianzhi Huang; Charles X Lei; C David James; John A Kessler; Cameron W Brennan; Ichiro Nakano; Xinghua Lu; Bo Hu; Wei Zhang; Shi-Yuan Cheng Journal: Epigenetics Date: 2018-08-06 Impact factor: 4.528
Authors: Shantanu Sur; Mustafa O Guler; Matthew J Webber; Eugene T Pashuck; Masao Ito; Samuel I Stupp; Thomas Launey Journal: Biomater Sci Date: 2014-06-01 Impact factor: 6.843